Nephrology News and Research

RSS

Nephrology is a branch of internal medicine and pediatrics dealing with the study of the function and diseases of the kidney.

Educational intervention may increase awareness about kidney transplant recipients' risk of developing skin cancer

Sharing printed educational materials about the risk of squamous cell carcinoma with kidney transplant recipients appeared to be effective at increasing skin self-examination and encouraging follow-up with a dermatologist to determine risk of cancer, according to a report posted online today that will appear in the June issue of Archives of Dermatology, one of the JAMA/Archives journals.

22 Feb 2011

Loyola forms new sixth research-focused transplant institute at LUHS

From the world's first successful kidney transplant to the first successful heart transplant performed in Illinois, Loyola University Health System has always been a pioneer in organ transplant research, education and clinical care.

21 Feb 2011

Cerebral oximetry provides new way to identify patient risk levels prior to cardiac surgery

Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today announced that its INVOS™ Cerebral/Somatic Oximeter can provide a simple, noninvasive way to help cardiac surgeons assess patients at risk for poor outcomes prior to surgery.

21 Feb 2011

Scientists identify new cellular mechanism underlying hydronephrosis

One of the most common congenital defects in humans - it is detected in approximately 0.5% of fetuses analyzed by routine antenatal sonography - is a kidney abnormality known as hydronephrosis. Hydronephrosis arises because the flow of urine from the kidney to the bladder is impeded.

21 Feb 2011

Artificial blood vessel could be available ‘off the shelf’ soon

Soon artificial blood vessels could be available ‘off the shelf’. This would mean that heart bypass patients would not have to be subjected to a minor operation to graft veins from other parts of their body. This would also make life easier for surgeons as well.

20 Feb 2011

Québec-Transplant: 371 persons benefited from transplant in 2010

Thanks to 119 deceased organ donors, 371 persons benefited from a transplant in 2010. Unfortunately, there were also 46 deaths among people on the waiting list (compared to 58 in 2009), many of which could have been avoided. As of December 31, 2010, 1,241 people were registered on the single waiting list managed by Québec-Transplant.

19 Feb 2011

Positive results from Medtronic CoreValve System study for treatment of aortic valve disease

Medtronic, Inc. today issued a statement on results from an independent study published online in the journal Circulation, which confirmed both early and sustained clinical benefits for patients receiving the Medtronic CoreValve® System for the treatment of aortic valve disease.

19 Feb 2011

Study: Low levels of Klotho protein may serve as early warning sign of CKD

Low levels of the anti-aging hormone Klotho may serve as an early warning sign of the presence of kidney disease and its deadly cardiovascular complications, according to findings by UT Southwestern Medical Center researchers.

18 Feb 2011

Fine-Gray competing-risks analysis may predict ESRD mortality in patients with type 1 diabetes

Patients with both type 1 diabetes and CKD have an increased risk of adverse outcomes. Despite aggressive treatment, many patients with type 1 diabetes and overt nephropathy develop End-Stage Renal Disease and/or succumb to a premature death. The competing risks of death and ESRD may confound the estimates of risk for each outcome.

18 Feb 2011

Cytochroma initiates CTAP101 repeat-dose safety, efficacy study in vitamin D insufficiency, SHPT and CKD

Cytochroma today announced the initiation of a repeat-dose safety and efficacy study of CTAP101 Capsules in patients with vitamin D insufficiency, secondary hyperparathyroidism (SHPT) and stage 3 chronic kidney disease (CKD).

17 Feb 2011

Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Symposium

Genomic Health, Inc. today announced the presentation of two studies at the American Society of Clinical Oncology® (ASCO®) Genitourinary (GU) Cancer Symposium, including complete results from its prostate cancer gene identification study, which identified 295 genes strongly associated with clinical recurrence following radical prostatectomy with great consistency across multiple tumor samples examined in each patient.

17 Feb 2011

ASN opposes proposed $1.6 billion reduction to NIH budget

Proposed cuts to the National Institutes of Health (NIH) budget for 2011 will limit the nation's ability to advance patient care and public health.

17 Feb 2011

Astellas, AVEO enter development, commercialization agreement for tivozanib

Astellas Pharma Inc., a global pharmaceutical company, and AVEO Pharmaceuticals, Inc. today announced that they have entered into a worldwide agreement outside of Asia to develop and commercialize tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad range of cancers.

17 Feb 2011

Scientists to present research on RMI ability to classify lung, kidney tumors at USCAP meeting

Clinical researchers from Cornell Weil Medical School and University of Chicago Medical School will present research conducted on Raman Molecular Imaging's ability to differentiate diagnostic dilemmas in lung and kidney tumors at the United States and Canadian Academy of Pathology's 100th Annual Meeting, Feb. 26-March 4 at the Henry B. Gonzalez Convention Center, San Antonio, Texas.

16 Feb 2011

First lung cancer treatment with BSD's MicroThermX ablation system delivered at Rhode Island Hospital

BSD Medical Corporation today announced the successful delivery of its first lung cancer patient treatment with the MicroThermX® Microwave Ablation System. The treatment was conducted by Damian E. Dupuy, M.D., at The Comprehensive Cancer Center at Rhode Island Hospital in Providence, Rhode Island.

16 Feb 2011

Bioniche presentation focuses on implementing E. coli cattle vaccine to reduce risk of human infection

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, gave a presentation about its E. coli O157 cattle vaccine at the First International One Health Congress in Melbourne, Victoria, Australia.

16 Feb 2011

Patient on artificial heart receives heart and kidney transplant

Charles Okeke, the Phoenix husband and father of three, made headlines in May 2010 when he became the first patient in the U.S. to be discharged from a hospital with an artificial heart. With the latest technology, the "Freedom Driver," the man without a heart was able to resume his family life and to be free of the confines of a hospital room.

16 Feb 2011

Roundup: States grapple with high health costs, Medicaid squeeze

Gov. Scott Walker's budget repair bill would give his administration sweeping powers to reshape state health programs covering more than 1 million state residents. Under the bill, the administration's rewrite of the Medicaid program would be reviewed only by the Legislature's budget committee, which has a broader margin of control for majority Republican lawmakers than any other legislative committee.

16 Feb 2011

UC Davis and Sutter first to share electronic health records in the region

Steven Hedrick, deputy director of rehabilitative programs at the California Department of Corrections, was relaxing at home recently when a sharp pain rippled through his lower abdomen. The ache was so severe that he drove to the nearest treatment center Sutter Urgent Care, Yuba City. Physicians there quickly evaluated Steven, obtained a CT scan and diagnosed him with kidney stones. Hedrick was prescribed pain medication and counseled to check in with his primary care physician at UC Davis as soon as possible.

15 Feb 2011

Idera: IMO-3100 in lupus preclinical model suppressed several key disease progression parameters

Idera Pharmaceuticals, Inc. announced today that it is presenting data on IMO-3100, an antagonist of TLR7 and TLR9, in a preclinical model of lupus showing that treatment with IMO-3100 suppressed several key disease progression parameters.

15 Feb 2011

Nephrology News and Research

Further Reading

Educational intervention may increase awareness about kidney transplant recipients' risk of developing skin cancer

Loyola forms new sixth research-focused transplant institute at LUHS

Cerebral oximetry provides new way to identify patient risk levels prior to cardiac surgery

Scientists identify new cellular mechanism underlying hydronephrosis

Artificial blood vessel could be available ‘off the shelf’ soon

Québec-Transplant: 371 persons benefited from transplant in 2010

Positive results from Medtronic CoreValve System study for treatment of aortic valve disease

Study: Low levels of Klotho protein may serve as early warning sign of CKD

Fine-Gray competing-risks analysis may predict ESRD mortality in patients with type 1 diabetes

Cytochroma initiates CTAP101 repeat-dose safety, efficacy study in vitamin D insufficiency, SHPT and CKD

Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Symposium

ASN opposes proposed $1.6 billion reduction to NIH budget

Astellas, AVEO enter development, commercialization agreement for tivozanib

Scientists to present research on RMI ability to classify lung, kidney tumors at USCAP meeting

First lung cancer treatment with BSD's MicroThermX ablation system delivered at Rhode Island Hospital

Bioniche presentation focuses on implementing E. coli cattle vaccine to reduce risk of human infection

Patient on artificial heart receives heart and kidney transplant

Roundup: States grapple with high health costs, Medicaid squeeze

UC Davis and Sutter first to share electronic health records in the region

Idera: IMO-3100 in lupus preclinical model suppressed several key disease progression parameters

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News